INS and type 2 diabetes mellitus: Our findings are in agreement with those of Veleba et al11 who reported an increase in fasting and postprandial plasma glucose concentrations, with no change in markers of insulin sensitivity, when metformin treated T2D individuals were supplemented with omega-3 FA (⁓2.8 g EPA+DHA/day) for 24 weeks.